Nuclear TAZ immunoreactivity was demonstrated in a variety of sarcoma types, most significantly in AS (55%; 16/29), MPNST (71%; 32/45) and MLS (55%; 47/85). The gene discussed is WWTR1; the disease is sarcoma.